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PhagocytosisThe inﬂammatory response to pathogen-associatedmolecular patterns such as lipopolysaccharide (LPS) in sepsis
is mediated via Toll-like receptors (TLRs). Since TLRs also trigger various immune functions, including phagocy-
tosis, theirmodulation is a promising strategy in the treatment of sepsis. As antibiotics have immunomodulatory
properties, this study examined the effect of commonly used classes of antibiotics on i) the expression of TLRs and
cytokines and ii) the phagocytic activity under sepsis-like conditions in vitro. This was achieved by incubating
THP-1monocytes and peripheral bloodmononuclear cells (PBMCs) obtained from patients after open-heart sur-
gery with the addition of LPS and six key antibiotics (piperacillin, doxycycline, erythromycin, moxiﬂoxacin or
gentamicin). After 24 h, mRNA levels of both cytokines (IL-1β, IL-6) and TLRs (1, 2, 4, and 6) were monitored
and phagocytosis was determined following coincubation with Escherichia coli. Each antibiotic differentially reg-
ulated the gene expression of the investigated TLRs and cytokines inmonocytes. Erythromycin, moxiﬂoxacin and
doxycyclin displayed the strongest effects and changed mRNA-levels of the investigated genes up to 5.6-fold.
Consistent with this, antibiotics and, in particular, moxiﬂoxacin, regulated the TLR-and cytokine expression in
activated PBMCs obtained from patients after open-heart surgery. Furthermore, piperacillin, doxycyclin and
moxiﬂoxacin inhibited the phagocytic activity of monocytes. Our results suggest that antibiotics regulate the im-
mune response by modulating TLR- and cytokine expression as well as phagocytosis under septic conditions.
Moxiﬂoxacin, doxycycline and erythromycin were shown to possess the strongest immunomodulatory effects
and these antibiotic classes should be considered for future immunomodulatory studies in sepsis.
© 2013 Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Sepsis is one of the leading causes of death in critically ill patients
and is associated with a hospital mortality of approximately 30% [1].
The clinical manifestation of sepsis is characterized by the cardinal
signs of inﬂammation including tachycardia, leukocytosis, tachypnea,
and pyrexia, which are collectively deﬁned as systemic inﬂammatory
response syndrome (SIRS). This systemic inﬂammatory response results
from excessive stimulation of innate immune cells by exposure to
different evolutionarily conserved molecular structures on infectiousgy and Intensive CareMedicine,
7 Bonn, Germany. Tel.:+49228
ode).
under CC BY-NC-ND license.microorganisms, known as “pathogen-associated molecular patterns”
(PAMPs)[2].
The recognition of PAMPs is mediated by pattern recognition recep-
tors (PRR) including the Toll-like receptors (TLRs), theNod-like receptors
(NLRs), the C-type lectin receptors (CLRs) and the RIG-like receptors
(RLRs) [3]. TLRs are the most widely studied PRRs and are considered
to be the primary sensors of pathogens [4]. Lipopolysaccharide (LPS) re-
leased from gram-negative bacteria is recognized by TLR4 and comprise
a major class of PAMP that causes sepsis through the induction of pro-
inﬂammatory cytokines such as IL-1β and IL-6 [4,5]. Beside their role in
the recognition of invading microbes, TLR-signaling further triggers the
clearance of pathogens by phagocytosis, which plays a key role in the
immune response during sepsis [6]. Due to the pivotal contribution of
TLRs in sepsis, their modulation and signaling pathways became a re-
search focus and it has been suggested that TLRs could be potential target
molecules for the treatment of sepsis [7–9].
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decade in new treatments for sepsis, almost all have failed to improve
outcomes and intervention with antibiotics remains one of the most
effective strategies. Antibiotics have widely appreciated bacteriostatic
or bactericidal properties and are used in the therapy of numerous in-
fections, including those associated with sepsis. Interestingly, some
antibiotics also directly modulate the immune system in addition to
exerting their antimicrobial properties. Thereby, antibiotics interact
with host immune cells and regulate their immune function, which
has beneﬁcial effects in various inﬂammatory conditions [10,11]. Previ-
ous studies have shown that antibiotics improve survival in animals
challenged with LPS or multidrug-resistant pathogens, suggesting an
immunomodulatory and non-antimicrobial effect of antibiotics under
septic conditions [12–15]. Furthermore, clinical data showed for the
ﬁrst time that the immunomodulatory properties of macrolide antibi-
otics improve the outcome of septic patients [16].
Yet, little is known about the molecular and cellular mechanisms by
which antibioticsmodulate the immune system during sepsis. Thus, the
aim of this study was to examine the effect of antibiotics on the expres-
sion of TLRs and sepsis-related cytokines under inﬂammatory condi-
tions that mimic sepsis. We focused on classes of antibiotics that are
commonly used in the treatment of sepsis and investigated their effects
on LPS-activated human immune cells, including leukocytes isolated
from patients with a systemic inﬂammatory response after open-heart
surgery. These research ﬁndings clearly indicate that the classes of
chinolones (moxiﬂoxacin), tetracyclines (doxycycline) and macrolides
(erythromycin) regulate the expression of TLRs and cytokines in septic
conditions. Thus, use of these antibiotics can be one useful clinical treat-
ment for septic patients.
2. Material and methods
2.1. Reagents and THP-1 cells
LPS from Escherichia coli (serotype 055:B5) was purchased from
Sigma-Aldrich (Taufkirchen, Germany) and antibiotics were obtained
from the manufacturer: gentamicin (GMC), piperacillin (PIP) and
doxycycline (DXC) from Ratiopharm (Ulm, Germany); erythromycin
(ERY) from Amdipharm (Dublin, Ireland) and moxiﬂoxacin (MXF) from
Bayer (Leverkusen, Germany). Human monocytic THP-1 cells (ATCC
TIB-202) [17] were grown in suspension in RPMI1640 (PAA, Coelbe,
Germany) containing 10% FCS (Biochrom, Berlin, Germany), 0.05 mM
2-mercaptoethanol (Sigma-Aldrich, Taufkirchen, Germany), 100 mg/mL
penicillin, 100 mg/mL streptomycin (both from Invitrogen, Frankfurt,
Germany) and were maintained at 37 °C in a humidiﬁed incubator
containing 5% CO2. The cells were cultured in antibiotic- and FCS-free
suspension for 48 h before experimental use to avoid any confounding
stimulation that might result from antibiotics or endotoxins present in
the cell culture medium. The viability of monocytes was determined by
the tryptan blue staining method. Cells with viability greater than 90%
were used for the experiments.
2.2. Patients and healthy volunteers
With the approval of the Ethics Committee of the Rheinische
Friedrich-Wilhelms-University Medical School in Bonn (number of ap-
proval: 125/08), and following written informed consent, we recruited
six healthy, non-smoking male volunteers and eight patients scheduled
to undergo cardiopulmonary bypass (CPB) for routine elective coronary
artery grafting. We excluded patients with acute or chronic infection,
immunocompromised patients, patients with autoimmune disorders,
or those taking immunosuppressive or anti-infective drugs in the pre-
cedingﬁve days. All patients underwent a routine procedurewithmedi-
an sternotomy and use of CPB. Anesthesia was induced with etomidate,
sufentanil and cisatracurium and was maintained using isoﬂurane
and sufentanil. Thereafter, the patients received 1.5 g cefuroxime asperioperative antibiotic prophylaxis. The CPB technique included non-
pulsatile ﬂow with moderate hypothermia (32 °C–34 °C) and the CPB
pump was primed with a standard electrolyte solution containing
10,000 IU heparin. Additional heparinwas given if the activated clotting
time failed to reach at least 480 s. Cardioplegia was induced by applica-
tion of Calaﬁore warm blood-cardioplegic solution. Weaning from CPB
was achieved after rewarming and inotropic support with epinephrine
(0.025–0.15 μg/kg/min) in all patients and additional norepinephrine
(0.025–0.15 μg/kg/min) as necessary. After CPB, heparin was neu-
tralized with protamine sulfate until the preoperative activated
clotting time was achieved. Postoperative ﬂuid management consisted
of isotonic-balanced electrolyte solution (30–40 ml/kg/day) for basic
replacement and gelatin, fresh frozen plasma, or packed red cells ac-
cording to hemodynamic status and laboratory parameters. Postopera-
tive antibiotic prophylaxis was performed with 3 × 1.5 g cefuroxime
every 8 h after admission on ICU.
2.3. Blood collection and preparation of peripheral blood mononuclear cells
Blood samples obtained from healthy volunteers were collected
by peripheral vein puncture. Patient blood samples were taken through
an indwelling central venous catheter before induction of anesthesia,
30 min and 24 h after end of surgery. In general, blood collection
was performed before routinely planned administration of antibiotic
prophylaxis. Monovette blood collecting system (Sarstedt, Nuembrecht,
Germany), containing EDTA as anticoagulant, was used. Peripheral
blood mononuclear cells (PBMCs) were immediately isolated from
blood samples by sucrose gradient (PANcoll, PAN-biotech, Aidenbach,
Germany) as described elsewhere [18]. After washing, PBMCs were
cultured as described above.
2.4. In vitro stimulation experiments
THP-1 cells and PBMCs at a concentration of 1 × 106 cells/mL in
6-well plates (Cellstar, Greiner bio-one, Frickenhausen, Germany)
were separately incubated in the presence of either LPS (10 μg/ml),
GMC (5 μg/ml), ERY (2 μg/ml), MXF (20 μg/ml), DXC (8 μg/ml), PIP
(100 μg/ml) or a combination of LPS with each antibiotic. The cells
were incubated at 37 °C and were removed from culture plates after
24 h for isolation of RNA.
2.5. Isolation of RNA and Real-time PCR
Total RNAwas isolated from the THP-1 cells and PBMCs using RNeasy
mini kit (Qiagen, Hilden, Germany) according to the manufacturer's
instructions. cDNA was generated from total RNA using the High Ca-
pacity cDNAReverse Transcription Kit (Applied Biosystems, Darmstadt,
Germany) as recommended by the manufacturer. Cycling conditions
were 25 °C for 10 min, 37 °C for 120 min, and 85 °C for 5 s. Real-time
PCRwas carried out on the 7900HT Fast Real-Time PCR system fromAp-
plied Biosystems using TaqMan Gene Expression Assays primer/probe
sets (Applied Biosystems) and the standard thermal-cycling conditions
for relative quantiﬁcation designed by themanufacturer. Quantiﬁcation
of the PCR signals for each sample was performed by comparing the
cycle threshold values in duplicate for the gene of interest with the
cycle threshold values for the GAPDH housekeeping gene. The mean
relative mRNA expression was determined by using the SDS software
V2.2 and the 2−ΔΔCT method [19].
2.6. Phagocytosis assay
The phagocytic activity of THP-1 cells was examined by measuring
the uptake of pHrodo E. coli BioParticles (Invitrogen) as described
by Wan et al. [20]. To prepare BioParticles, 2 ml of PBS were used for
reconstitution of the BioParticles. THP-1 cells (1 × 106 cells/ml) were
incubated with antibiotics in the presence or absence of LPS as
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pHrodo E. coli BioParticles for 2 h. DNA staining for viability mea-
surement was performed just prior to ﬂow cytometry analysis with
2 μg/ml Hoechst 33342 (Invitrogen). Flow cytometry was conducted
using a Canto III Flow Cytometer System (BD Biosciences, Heidelberg,
Germany) and FlowJo Analysis Software (Treestar, Ashland, OR, USA).
Phagocytic activity was expressed as the percentage of cells that per-
formed phagocytosis compared to the total number of viable monocytes.
2.7. Statistical analysis
Statistical analysiswas performed using GraphPad Prism5 (GraphPad
Software, La Jolla, CA, USA). Mann–Whitney U test was used to examine
differences in phagocytic assay and in gene expression of both THP-1
cells and PBMCs from healthy volunteers. Data obtained from CPB
surgery patients were analyzed by paired t-test. Values of p b 0.05 were
considered signiﬁcant. All data are expressed as mean ± SEM unless
otherwise noted.
3. Results
3.1. Antibiotics differentially modulate the gene expression of TLRs and
cytokines in monocytes
To determine a putative immunomodulatory effect of antibiotics in
sepsis, we initially incubated human THP-1 monocytes with clinically
relevant concentrations of commonly used classes of antibiotics, namely
PIP (beta-lactam), DXC (tetracycline), ERY (macrolide), MXF (quino-
lone), and GMC (aminoglycoside) in the presence or absence of LPS.
The expression of genes encoding IL-1β, IL-6, TLR1, TLR2, TLR4, and
TLR6 was monitored by RT-PCR after 24 h. Tested antibiotics showed
differential regulatory effects on gene expression of the investigated
cytokines and TLR-subtypes (Fig. 1). Themagnitude of this regulation dif-
fered between the various classes of antibiotics. Whereas ERY displayed
strong immunomodulatory properties in terms of increasing the geneFig. 1. Effect of antibiotics on cytokines and TLR expression in endotoxin-activated THP-1monocy
cin (ERY), moxiﬂoxacin (MXF) or gentamicin (GMC) in the presence or absence of LPS for 24 h. Q
levels of genes encoding IL-1β (A), IL-6 (B), TLR1 (C), TLR2 (D), TLR4 (E) and TLR6 (F) after nor
unstimulated control with antibiotic-incubated cells or LPS-stimulated control with LPS plus antiexpression up to 5.6-fold (TLR4; Fig. 1E; p b 0.05) in LPS-stimulated
cells, PIP only altered the mRNA levels up to 2.3-fold (TLR1; Fig. 1C;
p b 0.05) compared to LPS-activated controls. In detail, PIP increased
the expression of TLR1, TLR2, TLR4 and TLR6 by≈2-foldwhen compared
to unstimulated controls (Fig. 1C–F; p b 0.05). In co-stimulationwith LPS,
the number of genes regulated by the presence of PIP also included IL-1β
and IL-6 (Fig. 1A,B; p b 0.05). In contrast, cells incubated with either
DXC or GMC alone exhibited signiﬁcantly reduced mRNA levels of IL-1β
(DXC and GMC; Fig. 1A; p b 0.05), TLR1 (DXC, Fig. 1C; p b 0.05), TLR4
(GMC, Fig. 1E, p b 0.05) and TLR6 (DXC and GMC, Fig. 1F; p b 0.05).
Furthermore, co-incubation of monocytes with LPS led to a signiﬁcant
down-regulation of IL-6 by both DXC and GMC compared to their LPS-
stimulated controls (Fig. 1B; p b 0.05). The incubation of monocytes
with either ERY or MXF resulted in differential regulation of several
genes: THP-1 cells cultured in the presence of ERY alone showed signiﬁ-
cantly higher mRNA levels of IL-1β (p b 0.05), whereas ERY in combina-
tion with LPS reduced mRNA levels of IL-1β when compared to their
respective controls (Fig. 1B; p b 0.05). THP-1 monocytes stimulated
with ERY ± LPS exhibited signiﬁcantly increased mRNA levels of TLR1,
TLR2, TLR4 and TLR6 (Fig. 1C–F; p b 0.05). The activation status ofmono-
cytes also inﬂuenced the regulation of TLR4 gene expression by MXF.
In LPS-activated cells, MXF signiﬁcantly increased the TLR4 expression
2-fold, while MXF reduced the TLR4 mRNA level by more than 50% in
the absence of endotoxin (Fig. 1E; p b 0.05). Furthermore, MXF signiﬁ-
cantly reduced IL-6 and TLR6 expression when cultured in the absence
of LPS (Fig. 1B,F; p b 0.05) and reduced both IL-1β and IL-6 mRNA levels
in LPS-activated cells (Fig. 1A,B; p b 0.05).
3.2. Antibiotics differentially modulate the gene expression of TLRs and
cytokines in PBMCs
The immunomodulatory effects of antibiotics on a mixed immune
cell population were studied in PBMCs obtained from healthy human
donors and were stimulated under the same conditions as described
above. Consistent with the results from THP-1monocytes, PIP increasedtes. THP-1monocyteswere incubatedwith piperacillin (PIP), doxycycline (DXC), erythromy-
uantitative Real-Time-PCR (qRT-PCR) analysis was performed to determine the expression
malization to GAPDH. Each bar represents the fold-change in mRNA expression comparing
biotic-stimulated cells, respectively. Data are expressed as mean ± SEM; *, p b 0.05.
Table 1
Demographic data and perioperative characteristics of patients undergoing CPB surgery.
Patient characteristics (n = 8)
Age (Years) 72.5 ± 8.3
Weight (kg) 83.0 ± 12.8
Height (cm) 171.9 ± 8.5
Pre-operative ejection fraction (%) 61.0 ± 13.2
Perioperative Data
Duration of surgery (min) 258.6 ± 75.2
CPB time (min) 66.3 ± 12.4
ACC (min) 16.3 ± 23.5
Intubation time (h) 27.5 ± 9.5
Postoperative blood loss (ml) 1247.5 ± 466.4
Length of stay on ICU (h) 47.1 ± 26.7
Intraoperative red blood cell transfusion (n) 5/8
Postoperative red blood cell transfusion (n) 7/8
Values are presented as mean ± SD except for the number of transfused red blood cells.
CPB indicates cardiopulmonary bypass; ACC, aortic cross-clamping; ICU, intensive care
unit.
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levels of TLR4 and/or TLR6 in PBMCs compared to their unstimulated
controls (Fig. 2D–E; p b 0.05). Furthermore, down-regulation of TLR6
mRNA expression by both DXC and GMC was also found in LPS-
activated PBMCs (Fig. 2F; p b 0.05). In contrast to the observed im-
munosuppressive effects of antibiotics on cytokine expression in
the THP-1 cell line, PBMC cultured with DXC, MXF or GMC alone and
GMC in combinationwith LPS exhibited signiﬁcantly highermRNA levels
of IL-1β as compared to the respective controls (Fig. 2A, p b 0.05).
Furthermore, PBMCs cultured with MXF alone revealed signiﬁcantly
increased mRNA level of IL-6 compared to unstimulated cells (Fig. 2B;
p b 0.05).
3.3. Antibiotics differentially modulate the gene expression of TLRs and
cytokines in PBMCs from patients with a systemic inﬂammatory response
We next studied the immunomodulatory effects of antibiotics on
immune cells from patients with a systemic inﬂammatory response
after open-heart surgery to mimic conditions found in sepsis. Therefore,
PBMCs were isolated from 8 patients undergoing CPB-surgery before in-
duction of anesthesia as well as 30 min and 24 h after surgery, followed
by incubation with antibiotics and LPS as described above. The operation
was uncomplicated in all of the patients and their demographic data as
well as clinical proﬁle are presented in Table 1. All patients were broadly
immunostimulated, which was represented by a signiﬁcant increase in
the number of leukocytes after surgery (Table 2; p b 0.05). Yet, further
parameters to diagnose a SIRS after surgery could not be evaluated as
these were manipulated by routinely performed treatments such as
cardiac pacing and mechanical ventilation. Blood from two patients
could not be collected at 24 h after surgery due to their unstable condi-
tion. The PBMCs responded to the surgery by down-regulating mRNA
levels of TLR2 after 30 min and both IL-1β and IL-6 after 24 h comparedFig. 2. Effect of antibiotics on cytokine and TLR-expression in endotoxin-activated PBMCs from
cultured with piperacillin (PIP), doxycycline (DXC), erythromycin (ERY), moxiﬂoxacin (MXF)
IL-1β (A), IL-6 (B), TLR1 (C), TLR2 (D), TLR4 (E) and TLR6 (F) wasmeasured by quantitative Rea
control to antibiotic-incubated cells or LPS-stimulated control to LPS plus antibiotic-stimulated c
*, p b 0.05.to preoperative collected cells (Figs. 3 and 4B; p b 0.05). In LPS-activated
PBMCs, this effect was extended by up-regulation of IL-1β, IL-6, TLR1,
TLR4 and TLR6 in cells obtained after 30 min and down-regulation of
TLR2 in cells isolated 24 h after surgery compared to preoperative con-
trols (Figs. 3 and 4; p b 0.05). Those effects were partially modulated
by antibiotics, suggesting an immunomodulatory effect of antibiotics on
either one or both studied time points (Figs. 3 and 4).
Therefore, we analyzed the effect of antibiotics on gene expression
within each time point and found that in pre-operatively isolated
PBMCs DXC increased the expression both IL-1β and IL-6, while PIP,
DXC and MXF signiﬁcantly increased the mRNA levels of TLR2 and re-
duced the TLR1 gene expression compared to unstimulated cells (Figs. 3
and 4A,B; p b 0.05). Furthermore, PIP signiﬁcantly increased thehealthy human donors ex vivo. Freshly isolated PBMC from healthy human donors were
or gentamicin (GMC) in the presence or absence of LPS for 24 h and mRNA expression of
l-Time PCR. Data represent the fold-change inmRNA expression comparing unstimulated
ells, respectively. Data are expressed asmean ± SEMof 6 individual donors in each group;
Table 2
Perioperative laboratory data and vital parameters of patients undergoing coronary artery
bypass surgery.
Variable Preoperative End of CPB
(n = 8)
24 h postop
(n = 6)
Laboratory data
Leucocyte count (×109/L) 7.0 ± 1.2 13.6 ± 2.1⁎ 8.0 ± 2.7
Hemoglobin (mg/dL) 13.1 ± 1.2 10.5 ± 0.8 10.5 ± 0.8
Platelet count (×109/L) 224 ± 70 118 ± 65 117 ± 41
Vital Parameters
Heart rate (/min) 61 ± 18 96 ± 6a 95 ± 13a
Mean arterial pressure (mmHg)
73 ± 13
68 ± 6.7 83 ± 8
Temperature (°C) 36.3 ± 0.3 36.5 ± 0.7 37.8 ± 0.4
Values are presented as mean ± SD.
⁎ p b 0.05 vs. preoperative data.
a Patients received cardiac pacing.
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operatively collected PBMCs (Fig. 4D; p b 0.05). In LPS-activated
PBMCs, only ERY reduced the mRNA-level of TLR1 whereas GMC in-
creased IL-1β expression (Figs. 3A and 4A; p b 0.05). When PBMCs
were stimulated in vivo by surgery and collected 30 min after surgery,
PIP in co-stimulationwith LPS signiﬁcantly reduced theirmRNAexpres-
sion of TLR1 and TLR4 while TLR2 expression was increased compared
to LPS-activated controls (Fig. 4; p b 0.05). The down-regulation of
IL-1β and TLR2 by ERY also required the presence of LPS, whereas
MXF increased both IL-1β and TLR2 expression and decreased TLR4
and TLR6 expression in the absence of LPS. The presence of LPS was
also important for the regulatory activity of DXC: DXC alone signiﬁcant-
ly reduced TLR1 while DXC in combination with LPS increased TLR1 ex-
pression signiﬁcantly compared to their respective controls (Fig. 4A;
p b 0.05). When PBMCs were obtained from patients 24 h after CPBFig. 3. Effect of antibiotics on cytokine expression in endotoxin-activated PBMCs before, 30 min
before anesthesia, 30 min (End of CPB) and 24 h after operation (post op). Cells were cultur
or gentamicin (GMC) in the presence (solid bar) or absence (open bar) of LPS for 24 h and m
Data are expressed asmean ± SEM and normalized unstimulated cells, which were collected a
comparisons at the various time points * indicated p b 0.05.surgery, only MXF signiﬁcantly reduced the mRNA level of TLR4 while
no effect by other antibiotics was observed (Fig. 4C; p b 0.05).
3.4. Effect of antibiotics on bacterial phagocytosis
After monitoring an effect of antibiotics on the expression of TLRs,
which play a critical role in regulating the phagocytosis of bacteria [6],
we examined whether antibiotics may affect the phagocytosis of
immune cells. Therefore, THP-1 monocytes were stimulated with anti-
biotics and LPS as described above, followed by incubation with heat-
killed E. coli. As determined by ﬂow cytometry, the inclusion of PIP,
DXC, or MXF in combination with LPS during culturing decreased the
percentage of phagocytizing cells (Fig. 5; p b 0.05 and p b 0.01, respec-
tively). This effect was LPS-dependent as incubation with antibiotics
alone had no effect on the phagocytic activity (data not shown).
4. Discussion
The excessive inﬂammatory response to microbial pathogens in
sepsis is mediated via TLRs and their modulation might improve the
outcome of septic patients by limiting the pathological inﬂammation
[21]. Increasing evidence suggests that the immunomodulatory proper-
ties of antibiotics may have beneﬁcial effects in sepsis [12–15]. Yet,
the underlying molecular and cellular mechanisms including the effect
of antibiotics on TLR expression remains unclear. The current study
showed immunomodulatory properties of various classes of antibiotics
on the expression of TLRs and sepsis-associated cytokines. Those effects
were particularly found in immune cells that were activated by the
sepsis mediator LPS and during a systemic inﬂammatory response
after surgical trauma.
Innate immune cells, such as monocytes, play a central role in the
pathogenesis of sepsis and are rapidly stimulated by various PAMPs, in
particular LPS, originating from invading pathogens [2]. LPS triggers aand 24 h after CPB surgery. PBMCs from 8 patients undergoing CPB surgerywere obtained
ed with piperacillin (PIP), doxycycline (DXC), erythromycin (ERY), moxiﬂoxacin (MXF)
RNA expression of IL-1β (A) and IL-6 (B) was measured by quantitative Real-Time PCR.
t pre-operative time point. # indicates p b 0.05 compared to pre-anesthesia; in intergroup
Fig. 4. Effect of antibiotics on TLR expression in endotoxin-activated PBMCs before, 30 min and 24 h after CPB surgery. PBMCs from 8 patients undergoing CPB surgery were obtained
before anesthesia, 30 min (End of CPB) and 24 h after operation (post op). Cells were cultured with piperacillin (PIP), doxycycline (DXC), erythromycin (ERY), moxiﬂoxacin (MXF) or genta-
micin (GMC) in thepresence (solid bar) or absence (openbar) of LPS for 24 h andmRNAexpression of TLR1 (A), TLR2 (B), TLR4 (C), and TLR6 (D)wasmeasured by quantitativeReal-TimePCR.
Data are expressed as mean ± SEM and normalized to unstimulated cells, which were collected at pre-operative time point. # indicates p b 0.05 compared to pre-anesthesia; in intergroup
comparisons at the various time points * indicated p b 0.05.
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of inﬂammatory cytokines such as IL-1β and IL-6, via TLR4 [4]. Fur-
thermore, LPS-activation changes the expression of TLRs in immune
cells and leads to a differential response to subsequent PAMP expo-
sure, which can result in an excessive pro-inﬂammatory response or
immunocompromised status of a septic patient [22]. Consistent with
previous reports, we found that tetracyclines (DXC), macrolides (ERY)
and ﬂuoroquinolones (MXF) had anti-inﬂammatory properties, whichmanifest by inhibiting the expression of inﬂammatory cytokines in re-
sponse to LPS [13,23–25]. At the same time, beta-lactams (PIP) showed
pro-inﬂammatory effects by increasing mRNA levels of IL-1β and IL-6
[26]. Furthermore, the aminoglycoside GMC also reduced the mRNA
levels of IL-1β and IL-6 inmonocytes which is in agreementwith the ef-
fects of GMC on renal tubule cells [27]. We demonstrated regulatory
properties for all tested classes of antibiotics on TLR expression to a var-
ious extent. These effects ranged from modest effects found in GMC-
Fig. 5. Effect of antibiotics on phagocytosis of heat-inactivated E. coli by THP-1 cells. THP-1
cells were incubated with piperacillin (PIP), doxycycline (DXC), erythromycin (ERY),
moxiﬂoxacin (MXF) or gentamicin (GMC) in the presence of LPS for 24 h and were incu-
bated thereafter for 2 h with heat-killed rhodamine-conjugated E. coli. DNA staining for
viability measurement was performed just prior to ﬂow cytometry analysis with Hoechst
33342. Data show percentage of monocytes positive for phagocytosis determined by ﬂow
cytometry and are expressed as mean ± SEM; *, p b 0.05; **, p b 0.01.
33C. Bode et al. / International Immunopharmacology 18 (2014) 27–34incubated cells to a very signiﬁcant modulation of all investigated TLR-
subtypes by ERY. Interestingly, the observed effects of antibiotics on
monocytes did not correspond to the results observed in PBMCs. For
example, MXF increased the expression of IL-1β and IL-6 in PBMCs
whereas the same genes were down-regulated by MXF in monocytes.
This observation that antibiotics have different immunomodulatory
effects on monocytes and heterogeneous leukocyte populations such
as PBMCs, which consist of lymphocytes (T cells, B cells, and NK cells),
monocytes, and dendritic cells, has been previously described. Bailly
et al. demonstrated that the quinolone ciproﬂoxacin suppressed the
pro-inﬂammatory cytokine response to endotoxin in monocytes while
the treatment of a mixed cell population with ciproﬂoxacin increased
their expression [28,29]. These results suggest that cellular interactions
could modify monocytic TLR- and cytokine expression to a modulation
by antibiotics.
Although the current data do not provide evidence for the immuno-
modulation by antibiotics at protein levels, several studies showed that
the regulation of the investigatedmRNA for TLRs and cytokines is corre-
lated with the change in protein expression [30–32]. Thus, those ﬁnd-
ings suggest that antibiotics modulate the responsiveness of immune
cells to LPS, which might help to understand why antibiotics such as
the macrolide clarithromycin have beneﬁcial immunomodulatory ef-
fects during sepsis [16].
The molecular mechanisms that underlie the immunomodulatory ef-
fects of antibiotics are so far poorly understood. To the authors' knowl-
edge, no previous study has revealed the mechanisms causing the
observed effects of PIP and GMC on the immune response. Yet, DXC has
been identiﬁed to inhibit LPS-induced NO production by immune cells
in vitro [23]. DXC may also be responsible for the reduction of IL-1β and
IL-6 expression. In addition, tetracyclines such as DXC possess strong
chelating abilities, which have been associated with immunomodu-
latory effects by inhibiting protein kinase C (PKC) [33,34]. Since it
has been shown that PKC inhibitors reduce LPS-stimulated cytokine
secretion [35], the chelating abilities of DXC might also reduce the
IL-1β and IL-6 expression through PKC inhibition. The macrolid ERY
was found to block the activation of transcription factors NF-κB and
IRF3 [24,36], thereby reducing the production of both pro- and anti-
inﬂammatory cytokines. The inhibition of signaling pathways by ERY
depends on which PAMP the immune cell is activated by. While IRF3
is inhibited by ERY after LPS stimulation, no effect of ERY on NF-κB,
which is critical for the expression of IL1-β and IL-6, has been detected
[24]. Thus, the observed effect in the current study might be due to an
unknown molecular mechanism. In contrast to ERY, MXF also inhibitsthe activation of NF-κB by inhibition of I-κB degradation after LPS stim-
ulation [37]. Furthermore, MXF also blocks the activation of mitogen-
activated protein kinases, which leads to a suppression of pro-
inﬂammatory cytokines. These inhibitory effects of MXF on the TLR4/
LPS-signaling pathway could explain its anti-inﬂammatory properties
including the reduction of the pro-inﬂammatory cytokines IL-1β and
IL-6.
For the ﬁrst time, we found that the phagocytic activity of LPS-
stimulated THP-1 cells toward E. coli was inhibited by PIP, DXC and
MXF regardless of their effects on TLR expression. The inhibitingproper-
ties of MXF on the phagocytic activity have been previously described
for the internalization of the gram-positive bacterium Staphylococcus
aureus [38]. In contrast, another report showed that PIP enhances the
phagocytic activity of E. coli by murine macrophages [39]. However,
the comparison of studies on the phagocytic activity, which focus on
murine cells is limited asmurine and human immune cells differentially
express phagocytic receptors after LPS stimulation [40]. A TLR-
independentmodulation of these receptors, such as scavenger receptors
(SR) or CLRs, might explain inhibitory effects of PIP, DXC and MXF. This
constellation was previously described for the effect of the immuno-
modulatory agent resveratrol on the phagocytosis of bacteria by mono-
cytes [41]. There, resveratrol inhibited phagocytic activity of THP-1 cells
by reducing SR and CTRs expression regardless of TLR-signaling. Fur-
thermore, it has been demonstrated that different patterns of cytokines
can also modulate the activity of human phagocytes [42]. Since the ef-
fect of antibiotics on cytokine production is presumably not limited to
IL-1β and IL-6, the generation of a distinct pattern of cytokines by PIP,
DXC andMXF could be another reason for the observed effects of antibi-
otics on phagocytosis.
The examination of direct immunomodulatory effects of antibiotics
on immune cells from septic patients is limited due to preexisting com-
bined antibiotic treatment. Given that sepsis is considered a systemic in-
ﬂammatory response to a suspected or conﬁrmed infection, we
examined the effect of antibiotics on immune cells from patients after
open-heart surgery. This population exhibits a frequent and robust in-
ﬂammatory response, which is caused by surgical trauma, CPB, reperfu-
sion injury and endotoxemia [43,44].
As previously reported, the peak of the pro-inﬂammatory cytokine
expression occurred immediately after surgery [45,46]. Furthermore,
we observed increased cytokine production after LPS stimulation in im-
mune cells isolated at the end of the operation, whereas no cytokine re-
sponse to LPSwas detectable in cells collected 24 h post-operation. This
indicates an early increase in endotoxin sensitivity and late endotoxin
tolerance of the collected immune cells. Consistent with this, PBMCs
obtained directly after surgery showed an up-regulation of TLR4 expres-
sion that is also observed in septic patients [30]. The immunomodulato-
ry effect of antibiotics on PBMCs collected from patients before surgery
was in accordance with the effects observed in PBMCs from healthy do-
nors. We further found that all antibiotics (with the exception of GMC)
showed to a various extent effects on the expression of cytokines and/or
TLRs in immune cells that were in vivo activated though CPB surgery.
Here, MXF showed the most immunomodulatory effects. Furthermore,
the up-regulation of TLR2 expression and the reduction of TLR4 mRNA
levels by MXF were also observed in all investigated cell populations
including THP-1 monocytes.
Themodulation of the immune system via TLRs is a promising strat-
egy in the treatment of sepsis [7–9]. Current ﬁndings suggest that sever-
al classes of antibiotics, which are commonly used in the treatment of
sepsis, regulate the immune system in sepsis-like conditions through
modulation of the expression of TLRs and pro-inﬂammatory cytokines
as well as the phagocytotic activity. We found that these effects varied
in the antibiotics belonging to different classes and thus identiﬁed quin-
olones, tetracycline andmacrolides as classes with the highest potential
to modulate the TLR expression in septic conditions. Thus, these antibi-
otics should be considered for future immunomodulatory studies in
sepsis.
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